12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere’s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan

Nakazato Akira; Takakura Hiromasa; Ueda Naoko; Do Tram Anh; Takeda Noriaki; Watanabe Yukio; Shojaku Hideo

doi:10.1080/00016489.2022.2085325

12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere’s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan

Nakazato Akira, Takakura Hiromasa, Ueda Naoko, Do Tram Anh, Takeda Noriaki, Watanabe Yukio, Shojaku Hideo

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

本文言語	日本
ページ（範囲）	491-498
ジャーナル	Acta Oto-Laryngologica
巻	142
号	6
DOI	https://doi.org/10.1080/00016489.2022.2085325
出版ステータス	出版済み - 2022
外部発表	はい

文献へのアクセス

10.1080/00016489.2022.2085325

引用スタイル

Akira, N., Hiromasa, T., Naoko, U., Tram Anh, D., Noriaki, T., Yukio, W., & Hideo, S. (2022). 12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere’s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan. Acta Oto-Laryngologica, 142(6), 491-498. https://doi.org/10.1080/00016489.2022.2085325

@article{bc325fe51bc44bce88a1b1c867540e5a,

title = "12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere{\textquoteright}s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan",

author = "Nakazato Akira and Takakura Hiromasa and Ueda Naoko and {Tram Anh}, Do and Takeda Noriaki and Watanabe Yukio and Shojaku Hideo",

year = "2022",

doi = "10.1080/00016489.2022.2085325",

language = "日本",

volume = "142",

pages = "491--498",

journal = "Acta Oto-Laryngologica",

number = "6",

}

Akira, N, Hiromasa, T, Naoko, U, Tram Anh, D, Noriaki, T, Yukio, W & Hideo, S 2022, '12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere’s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan', Acta Oto-Laryngologica, vol. 142, no. 6, pp. 491-498. https://doi.org/10.1080/00016489.2022.2085325

12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere’s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan. / Akira, Nakazato; Hiromasa, Takakura; Naoko, Ueda その他.
In: Acta Oto-Laryngologica, Vol. 142, No. 6, 2022, p. 491-498.

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

TY - JOUR

T1 - 12-month effect of middle ear pressure therapy with the EFET01 device for intractable definite Meniere’s disease and delayed endolymphatic hydrops after certification by the public health insurance system in Japan

AU - Akira, Nakazato

AU - Hiromasa, Takakura

AU - Naoko, Ueda

AU - Tram Anh, Do

AU - Noriaki, Takeda

AU - Yukio, Watanabe

AU - Hideo, Shojaku

PY - 2022

Y1 - 2022

U2 - 10.1080/00016489.2022.2085325

DO - 10.1080/00016489.2022.2085325

M3 - 学術論文

VL - 142

SP - 491

EP - 498

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

IS - 6

ER -